Detecting Growing Tumors through Changes in the Plasma Proteome
In this GEN webinar, SomaLogic CSO Nebojsa Janjic, PhD, will discuss the need for a reliable blood-based screening method capable of detecting cancers earlier.
Organoids from Amniotic Fluid Cells: A Landmark Achievement That Will Broaden Research
In this GEN keynote webinar, Mattia Gerli, PhD, and Paolo De Coppi, MD, (University College London, Institute of Child Health) will reveal how their team achieved this landmark in organoid research.
Vaccine Development: Multiplexed Solutions on the InDevR VaxArray Platform
In this webinar, Dr. Kopcho from InDevr will demonstrate the flexibility of the VaxArray platform through a variety of case studies and customer examples that include the utility of InDevR’s off-the-shelf kits for influenza vaccines and pneumococcal conjugate vaccines, as well as a variety of custom kits.
dPCR vs. qPCR: Selecting the Right Tool for Molecular Analysis
In this GEN webinar, our panelists Jim Huggett, PhD, and Boshen Gao will introduce the dPCR workflow and discuss this technology’s advantages over traditional qPCR including higher precision, more flexibility, increased sensitivity, and true absolute quantification.
Using AI-Based Spatial Analysis to Explore Immunotherapy Biomarkers
In this GEN webinar, our speakers Ettai Markovits, MD, and Arutha Kulasinghe, PhD, will discuss how AI-based spatial analysis of mIF data can accelerate the discovery of clinically relevant biomarkers that can predict response and resistance mechanisms to immunotherapy.
Can Organoids Unlock the Pathology of Traumatic Brain Injuries?
In this GEN webinar, Justin Ichida, PhD, an expert in stem cell biology and regenerative medicine at the Keck School of Medicine, USC discusses using organoids to clear up the causes of neuronal damage following TBIs and ways of mitigating injury risks.
Simplifying Scale-up Manufacturing of RNA-LNPs for Vaccine and Cell Therapy Applications
In this GEN webinar, our expert speaker, Ian Johnston from Cytiva, discusses a genomic medicine toolkit for developing RNA-LNP medicines.
Neoantigen Identification: A Microfluidics-Assisted Workflow for Fine Needle Biopsies
In thi’s GEN webinar, Valo Therapeutics’ Senior Scientist, Dr. Joseph Ndika, will describe a workflow that leverages Valo Therapeutics’ innovative microfluidics-based immunoaffinity platform in combination with Bruker’s ultra-high sensitivity mass spectrometry, to identify tumor-specific HLA Class I antigens from as few as 10,000 cells.
QSP Modeling: How Biosimulation Can Bolster Cell and Gene Therapy Development
In this GEN webinar, our expert speakers will discuss how QSP modeling improves early feasibility assessment, rational therapy design, and clinical development of cell and gene therapies.
MaxFuse and Beyond: Empowering Spatial Biology with Integrated Computational Tools
In this GEN webinar, Enable Medicine’s Alex Trevino, PhD, discusses how AI-powered algorithms within the Enable platform facilitate comprehensive data storage, annotation, analysis, and search.
Complex mAb Purification: Challenges and Solutions
In this GEN webinar, our expert panelists Brian O’Mara from Scorpius BioManufacturing, Angela Lewandowski, PhD, from Bristol Myers Squibb, and Buzz Lobbezoo from Thermo Fisher will discuss key challenges in the purification process of complex mAbs and suggest strategies for mitigating their effects.
Detecting and Characterizing AAV Capsid Proteins and Transgenes in Gene Therapy Applications
In this GEN webinar, our expert speakers Benjamin McLeod, PhD, Sylvain Cecchini, PhD, Qimin Quan, PhD, and Angad Garg, PhD will introduce NanoMosaic’s Tessie™, a fit-for-purpose platform for gene therapy applications that effectively combines protein and nucleic acid quantification in a single run.
How AI-Supported Spatial Analysis and Multiplex Assays Elucidate the Tumor Microenvironment
In this GEN webinar, Michael Downing, Senior Image Analysis Scientist at Ultivue, will review the state of the field and introduce Ultivue’s two core platform technologies.
Precise Cell Engineering Using Base Editing Demonstrated by Single-Cell Multiomics
In this GEN webinar, our expert speakers will describe the Pin-point base editing platform and how it enables the creation of CAR-T therapies and hypoimmunogenic iPSCs in a single intervention by simultaneously introducing multiple gene knockouts and enabling site-specific integration of a transgene.
Uncovering RNA Splicing’s Cell-Specific Impact on Clonal Blood Disorders with GoT-Splice
In this GEN webinar, Dr. Mariela Cortés López will present a novel approach, GoT-Splice, developed by the Landau lab at the New York Genome Center in collaboration with the Abdel-Wahab lab at MSKCC that integrates genotyping of transcriptomes (GoT) with Oxford Nanopore long-read single-cell transcriptome profiling and proteogenomics.
Using iPSC-Derived Hepatocyte Models for Disease Modeling and Predictive Toxicology Screening
In this GEN webinar, our speakers Nikolaos Nikolaou and Dominic Williams will present new research into iPSC-derived hepatocyte models, how they compare to liver cancer cells lines, and why they are a better model for large-scale preclinical drug studies.